Study ID | Country | Disease duration, mean ± SD/median (range) | Women, % | Sample size | Age, mean ± SD/median (range), years | Criteria for detection of anxiety (cutoff) | Anxiety prevalence, % | Criteria for detection of depression (cutoff) | Depression prevalence, % | NOS |
---|---|---|---|---|---|---|---|---|---|---|
Abdul-Sattar 2015 | Egypt | 10.0 ± 4.6 years | 95% | 80 | 30.9 ± 11.7 |  |  | CES-D (>16.7) | 43.75 | 2 |
Appenzeller 2009 | Brazil | 64.5 ± 48.5 months | 94.6% | 167 | 32.1 ± 11.0 |  |  | 21 Item-BDI (≥10) | 20.9 | 2 |
Bachen 2009 | USA | 15.4 ± 9.7 years | 100% | 326 | 47.9 ± 11.3 | DSM-IV | 64 | DSM-IV | Major depressive disorder: 42.4, dysthymic disorder: 2.9 | 5 |
Bogdanovic 2015 | Serbia | 6.8 ± 2.9 years | 100% | 60 | 43.4 ± 12.8 |  |  | 21 Item-BDI (≥16/≥20/≥30) | 91.7/70/3.3 | 2 |
Calderon 2014 | Chile | Median: 32.0 (0–243.0) months | 100% | 82 | Median: 36.0 (17.0–64.0) |  |  | HADS (≥8) | 37 | 2 |
Cho 2014 | South Korea | NS | 90.1% | 201 | 41.3 ± 13.2 |  |  | CES-D (≥16) | 39.3 | 3 |
Chin 1993 | Malaysia | 4.1 ± 3.5 years | 95% | 79 | 31.1 ± 9.1 | ICD-9 and DSM-III | 7.6 | ICD-9 and DSM-III | Major depressive disorder: 6.3, dysthymic disorder: 32.9 | 2 |
Da Costa 2005 | Canada | 13.8 ± 10.1 years | 100% | 100 | 45.4 ± 14.0 |  |  | CES-D (≥16) | 31 | 3 |
Doria 2004 | Italy | 9.9 ± 6.3 years | 87.3% | 126 | 38.9 ± 11.9 | HAS (≥6/≥15) | 74.6/27 | HDS (≥8/≥16) | 40.5/2.4 | 2 |
Duvdevany 2011 | Israel | 11.4 ± 9.1 years | 88% | 100 | 37.0 ± 11.8 | HADS (≥8) | 20 | HADS (≥8) | 37 | 4 |
GarcÃa-Carrasco 2011 | Mexico | 106.5 ± 85.5 months | 100% | 106 | 40.5 ± 12.0 |  |  | CES-D (≥16) | 38.8 | 2 |
GarcÃa-Carrasco 2013 | Mexico | 10.5 ± 7.4 years | 100% | 105 | 43.6 ± 11.3 |  |  | CES-D (≥16) | 33 | 2 |
Greco 2009 | USA | 16.3 ± 7.0 years | 100% | 161 | 50.1 ± 10.0 |  |  | CES-D (≥16) | 27 | 2 |
Hanly 2015 | Canada | 5.6 ± 4.8 years | 88.9% | 1827 | 35.1 ± 13.3 |  |  | DSM-IV | 12.7 | 4 |
Harrison 2006 | USA | 15.3 ± 3.2 years | 100% | 93 | 43.3 ± 13.7 |  |  | CES-D (>27) | 16.1 | 2 |
Huang 2007 | China | 7.5 ± 6.9 years | 91.5% | 129 | 37.4 ± 10.7 | HADS (≥8) | 32 | HADS (≥8) | 20 | 2 |
Iverson 2002 | Canada | NS | NS | 103 | NS |  |  | 21 Item-BDI (≥17) | 39.8 | 1 |
Jarpa 2011 | Chile | Median: 5.0 (0.1–40.0) years | 90.8% | 87 | Median: 39.0 (16.0–27.0) | DSM-IV | 18.1 | DSM-IV | Major depressive disorder: 21.7, dysthymic disorder: 4.8 | 2 |
Julian 2011 | USA | 15.8 ± 9.3 years | 93% | 150 | 48.8 ± 12.3 |  |  | ICD-10 and DSM-IV | Major depressive disorder: 17, dysthymic disorder: 4, minor depression: 6 | 3 |
Jung 2015 | Korea | 6.8 ± 4.4 years | 93% | 100 | 40.6 ± 10.3 |  |  | 21 Item-BDI (≥21) | 13 | 2 |
Katz 2011 | USA | 13.6 ± 8.5 years | 100% | 716 | 48.1 ± 12.6 |  |  | CES-D (≥24) | 25 | 3 |
Karol 2013 | USA | NS | 93% | 127 | 38.1 ± 12.3 |  |  | 21 Item-BDI (≥18) | 41.7 | 2 |
Karimifar 2013 | Iran | 4.1 ± 0.5 years | 80% | 100 | 34.8 ± 10.9 |  |  | 21 Item-BDI (≥14) | 60 | 2 |
Kheirandish 2015 | Iran | 9.0 ± 7.7 years | 92.2% | 166 | 33.1 ± 11.1 | Cattell questionnaire (≥21) | 84.9 | 21 Item-BDI (≥5/≥30) | 64.5/9 | 2 |
Kotsis 2014 | Greece | 13.2 ± 9.1 years | 84% | 75 | 44.1 ± 13.3 |  |  | PHQ-9 (≥10) | 29.3 | 2 |
Kim 2015 | USA | 12.0 ± 8.0 years | 93% | 89 | 39.0 ± 15.0 |  |  | CES-D (≥16) | 63 | 3 |
Lapteva 2006 | USA | 13.8 ± 10.2 years | 75% | 60 | 41.0 ± 13.0 |  |  | DSM-IV | Major depressive disorder: 16.6 | 2 |
Lisitsyna 2014 | NS | 134.9 ± 8.8 months | 85.6% | 180 | 34.6 ± 0.93 |  |  | ICD-10 | Major depressive disorder: 24.4, dysthymic disorder: 25.6, adjustment disorders: 18.9 | 2 |
Mak 2011 | Singapore | 54.9 ± 70.7 months | 88% | 60 | 40.5 ± 12.9 | HADS (≥8) | 38 | HADS (≥8) | 22 | 2 |
Maneeton 2013 | Thailand | 6.1 ± 4.8 years | 98% | 62 | 31.8 ± 9.0 | HAS (≥14) | 37.1 | HDS (≥11) | 45.2 | 2 |
Mirbagher 2016 | Iran | 8.3 ± 3.8 years | 100% | 77 | 36.5 ± 10.1 | HADS (≥8) | 71.4 | HADS (≥8) | 46.1 | 3 |
Monaghan 2007 | Australia | 10.2 ± 8.7 years | 97% | 60 | 44.4 ± 12.2 | HADS (≥8) | 44 | HADS (≥8) | 36 | 3 |
Montero-Lo’pez 2016 | Spain | 0.2 ± 0.7 years | 100% | 97 | 38.6 ± 9.3 | SCL-90-R | 4.1 | SCL-90-R | 5.2 | 2 |
Nery 2008 | Brazil | 9.8 ± 6.5 years | 100% | 71 | 34.8 ± 10.1 | SCID for DSM-IV | 46.5 | SCID for DSM-IV | Major depressive disorder: 40.8 | 2 |
Neville 2014 | Canada | 10.2 ± 9.5 years | 92.4% | 612 | 46.8 ± 16.7 |  |  | PHQ-2 (≥3) | 28.1 | 4 |
Palagini 2014 | Italy | 15.0 ± 8.0 years | 100% | 81 | 43.6 ± 11.2 | SAS (>44) | 17.3 | 21 Item-BDI (≥11) | 34.6 | 3 |
Panopalis 2010 | USA | 13.8 ± 8.9 years | 91% | 807 | 47.6 ± 13.1 |  |  | CES-D (≥16) | 38.5 | 5 |
Pettersson 2015 | Sweden | Median: 12.0 years | 92% | 305 | Median: 48 | HADS (≥8) | 34 | HADS (≥8) | 51 | 4 |
Postal 2016 | Brazil | Median: 9.0 (0–33.0) years | 96.7% | 153 | Median: 30.0 (10.0–62.0) | 21 Item-BAI (≥8/≥16/≥26) | 60.7/43.1/18.3 | 21 Item-BDI (≥14/≥20/≥29) | 45.7/30.7/18.9 | 2 |
Radhakrishan 2011 | India | NS | 100% | 100 | 18-60 | SCID for DSM-IV | 51 | SCID for DSM-IV | Major depressive disorder: 46, adjustment disorder: 21, dysthymic disorder: 9 | 2 |
Roebuck-Spencer 2006 | USA | 13.8 ± 10.2 years | 80% | 60 | 41.3 ± 12.8 |  |  | 21 Item-BDI (≥14) | 20 | 2 |
Segal 2012 | USA | 12.0 ± 2.3 years | 93% | 71 | 41.7 ± 1.5 |  |  | CES-D (≥16) | 39 | 2 |
Sehlo 2013 | Saudi Arabia | 6.9 ± 4.2 years | 100% | 80 | 34.8 ± 11.2 |  |  | SCID for DSM-IV | Major depressive disorder: 11.25 | 2 |
Sfikakis 1998 | Greece | 7.8 ± 6.4 years | 91.5% | 71 | 37.0 ± 13.0 | HAS (>17) | 23.9 | HDS (>17) | 19.7 | 2 |
Shakeri 2015 | Iran | NS | 92.5% | 160 | 30.1 ± 6.2 | 21 Item-BAI (≥8/≥16/≥26) | 81.2/51.9/18.1 | 21 Item-BDI (≥21/≥31/>40) | 69.3/38.7/20.6 | 2 |
Shen 2015 | China | NS | 91.2% | 156 | 32.9 ± 10.2 | Zung SAS (≥50) | 20.51 | Zung SDS (≥53) | 33.33 | 3 |
Skare 2014 | Brazil | 8.2 ± 6.9 years | 93% | 100 | 39.2 ± 12.5 |  |  | 21 Item-BDI (≥19/≥ 30) | 21/2 | 2 |
Shorta1l 1995 | England | 11.0 ± 7.1 years | 95% | 80 | 41.0 ± 11.2 | HADS (≥8) | 39 | HADS (≥8) | 26 | 2 |
Stoll 2001 | Switzerland | 11.4 ± 9.0 years | 90% | 60 | 44.5 ± 15.4 |  |  | HADS (≥8) | 16 | 3 |
Tam 2008 | China | 9.7 years | 95.9% | 291 | 42.0 ± 12.0 | HADS (≥8) | 22 | HADS (≥8) | 18.2 | 3 |
Tay 2015 | Singapore | 72.3 ± 81.1 months | 86.4% | 110 | 38.7 ± 12.6 | HADS (≥8) | 40.9 | HADS (≥8) | 15.5 | 2 |
Tench 2000 | England | Median: 36.0 (12.0–79.5) months | 100% | 120 | Median: 38.0 (32.0–45.0) | HADS (≥8) | 60 | HADS (≥8) | 37 | 2 |
Tjensvoll 2010 | Norway | 12.3 ± 8.6 years | 87% | 63 | 43.4 ± 13.3 |  |  | 21 Item-BDI (≥13) | 23.8 | 2 |
Utset 2014 | USA | Median: 9Â years | 95% | 344 | >18 | Â | Â | CES-D (>10) | 54.5 | 4 |
van Exel 2013 | Netherlands | 7.8 ± 7.0 years | 88.2% | 102 | 44.4 ± 12.5 |  |  | 21 Item-BDI (≥14) | 27 | 3 |
Vina 2015 | USA | 143.2 ± 117.8 months | 93% | 343 | 44.4 ± 12.9 |  |  | CES-D (≥17) | 47.2 | 4 |
Weder-Cisneros 2004 | USA | Mean: 97.0 (6–348) months | 91.4% | 81 | 31.2 ± 9.7 |  |  | 21 Item-BDI (≥14) | 40.7 | 3 |
Xie 2012 | China | Median: 1.3 years | 93.7% | 285 | 34.0 ± 13.0 |  |  | 21 Item-BDI (≥5/14/≥21) | 59.3/40.7/19.3 | 4 |
Zakeri 2012 | Iran | NS | 90.5% | 71 | >18 |  |  | 21 Item-BDI (≥16/≥32) | 60/9.4 | 2 |